Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-18

Clinical Trial Update: Drug-Eluting Bead-Based Transarterial Chemoembolization (DEB-TACE) as a Local Salvage Therapy for Large Lesions in Relapsed and Refractory Diffuse Large B-Cell Lymphoma

View source ↗

Summary

A clinical trial is recruiting to evaluate drug-eluting bead-based transarterial chemoembolization (DEB-TACE) as local salvage therapy for large lesions in rela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Drug-eluting bead-based transarterial chemoembolization (DEB-TACE)

Snippet

Sponsor: Ting YANG | Conditions: Diffuse Large B-Cell Lymphoma, Relapsed and Refractory | Status: RECRUITING